Kong M, Guo L, Xu W, He C, Jia X, Zhao Z
Life Med. 2025; 1(2):149-167.
PMID: 39871923
PMC: 11749795.
DOI: 10.1093/lifemedi/lnac014.
Tang J, Du K
Cell Biosci. 2025; 15(1):9.
PMID: 39856740
PMC: 11762502.
DOI: 10.1186/s13578-025-01351-8.
Wen H, Deng H, Li B, Chen J, Zhu J, Zhang X
Signal Transduct Target Ther. 2025; 10(1):9.
PMID: 39788934
PMC: 11724432.
DOI: 10.1038/s41392-024-02044-3.
Lin T, Liu D, Guan Z, Zhao X, Li S, Wang X
Heliyon. 2024; 10(8):e29382.
PMID: 38660246
PMC: 11040068.
DOI: 10.1016/j.heliyon.2024.e29382.
Qiu J, Wu H, Xie Q, Zhou Y, Gao Y, Liu J
Front Bioeng Biotechnol. 2024; 12:1372211.
PMID: 38655388
PMC: 11035818.
DOI: 10.3389/fbioe.2024.1372211.
Secondary follicles enable efficient germline mtDNA base editing at hard-to-edit site.
Xie Q, Wu H, Long H, Xiao C, Qiu J, Yu W
Mol Ther Nucleic Acids. 2024; 35(2):102170.
PMID: 38560422
PMC: 10979202.
DOI: 10.1016/j.omtn.2024.102170.
Generation of mitochondrial replacement monkeys by female pronucleus transfer.
Li C, Liu X, Li Y, Wang Y, Nie Y, Xu Y
Zool Res. 2024; 45(2):292-298.
PMID: 38485499
PMC: 11017074.
DOI: 10.24272/j.issn.2095-8137.2023.287.
Compact zinc finger architecture utilizing toxin-derived cytidine deaminases for highly efficient base editing in human cells.
Fauser F, Kadam B, Arangundy-Franklin S, Davis J, Vaidya V, Schmidt N
Nat Commun. 2024; 15(1):1181.
PMID: 38360922
PMC: 10869815.
DOI: 10.1038/s41467-024-45100-w.
Mitochondrial genome editing: strategies, challenges, and applications.
Lim K
BMB Rep. 2024; 57(1):19-29.
PMID: 38178652
PMC: 10828433.
Enhanced C-To-T and A-To-G Base Editing in Mitochondrial DNA with Engineered DdCBE and TALED.
Wei Y, Jin M, Huang S, Yao F, Ren N, Xu K
Adv Sci (Weinh). 2023; 11(3):e2304113.
PMID: 37984866
PMC: 10797475.
DOI: 10.1002/advs.202304113.
Developing mitochondrial base editors with diverse context compatibility and high fidelity via saturated spacer library.
Sun H, Wang Z, Shen L, Feng Y, Han L, Qian X
Nat Commun. 2023; 14(1):6625.
PMID: 37857619
PMC: 10587121.
DOI: 10.1038/s41467-023-42359-3.
Engineering RsDddA as mitochondrial base editor with wide target compatibility and enhanced activity.
Cheng K, Li C, Jin J, Qian X, Guo J, Shen L
Mol Ther Nucleic Acids. 2023; 34:102028.
PMID: 37744175
PMC: 10514076.
DOI: 10.1016/j.omtn.2023.09.005.
Base editors: development and applications in biomedicine.
Liang Y, Chen F, Wang K, Lai L
Front Med. 2023; 17(3):359-387.
PMID: 37434066
DOI: 10.1007/s11684-023-1013-y.
Trends and prospects in mitochondrial genome editing.
Phan H, Lee H, Kim K
Exp Mol Med. 2023; 55(5):871-878.
PMID: 37121968
PMC: 10238537.
DOI: 10.1038/s12276-023-00973-7.
Mitochondrial Base Editing: Recent Advances towards Therapeutic Opportunities.
Kar B, Castillo S, Sabharwal A, Clark K, Ekker S
Int J Mol Sci. 2023; 24(6).
PMID: 36982871
PMC: 10056815.
DOI: 10.3390/ijms24065798.
Modeling mitochondrial DNA diseases: from base editing to pluripotent stem-cell-derived organoids.
Tolle I, Tiranti V, Prigione A
EMBO Rep. 2023; 24(4):e55678.
PMID: 36876467
PMC: 10074100.
DOI: 10.15252/embr.202255678.
Direct evidence of CRISPR-Cas9-mediated mitochondrial genome editing.
Bi R, Li Y, Xu M, Zheng Q, Zhang D, Li X
Innovation (Camb). 2022; 3(6):100329.
PMID: 36275864
PMC: 9579715.
DOI: 10.1016/j.xinn.2022.100329.
Precision mitochondrial DNA editing with high-fidelity DddA-derived base editors.
Lee S, Lee H, Baek G, Kim J
Nat Biotechnol. 2022; 41(3):378-386.
PMID: 36229610
PMC: 10017512.
DOI: 10.1038/s41587-022-01486-w.
Enhanced mitochondrial DNA editing in mice using nuclear-exported TALE-linked deaminases and nucleases.
Lee S, Lee H, Baek G, Namgung E, Park J, Kim S
Genome Biol. 2022; 23(1):211.
PMID: 36224582
PMC: 9554978.
DOI: 10.1186/s13059-022-02782-z.
CRISPR-free base editors with enhanced activity and expanded targeting scope in mitochondrial and nuclear DNA.
Mok B, Kotrys A, Raguram A, Huang T, Mootha V, Liu D
Nat Biotechnol. 2022; 40(9):1378-1387.
PMID: 35379961
PMC: 9463067.
DOI: 10.1038/s41587-022-01256-8.